-
admin
Posts
H.I.G. Capital Closes $1 Billion Bayside Loan Opportunity Fund VII
MIAMI, Dec. 5, 2024 /PRNewswire/ — H.I.G. Bayside Capital, the special situations credit affiliate of H.I.G. Capital (“H.I.G.” or the “Firm”), a leading global alternative investment...
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
EAST RUTHERFORD, N.J., Dec. 5, 2024 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has signed an agreement...
87% of legal industry users say DeepL’s Language AI platform helps them work faster, finds new research
DeepL unveils new report on the state of AI within the legal sector, including industry trends, challenges, and what’s ahead in 2025 NEW YORK, Dec....
Abercrombie & Fitch Co. Expands into India; Inks Strategic Franchise Partnership with Myntra Jabong
Agreement supports long-term opportunity for global, omnichannel growth for the Abercrombie & Fitch and Hollister brands NEW ALBANY, Ohio, Dec. 04, 2024 (GLOBE NEWSWIRE) —...
Five Below, Inc. Names Winnie Park Chief Executive Officer
Seasoned retail executive to lead next phase of growth for extreme-value retailer PHILADELPHIA, PA, Dec. 04, 2024 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE),...
Special Olympics Florida’s Race for Inclusion – Miami is Here
Fundraising Campaign and Social Movement Supports Floridians with Intellectual Disabilities MIAMI, Dec. 04, 2024 (GLOBE NEWSWIRE) — Special Olympics Florida will host the Race for...
Americas Cosmetics and Toiletries Industry Opportunities Report 2024
The report provides an overview of current cosmetics & toiletries industry scenario regarding the future outlook in terms of ingredients, product claims, labeling, distribution, and...
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of November 30, 2024
Press ReleaseVELIZY-VILLACOUBLAY, France — December 4, 2024 Declaration of the number of outstanding shares and voting rights as of November 30, 2024 Dassault Systèmes (Euronext...
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease NEW YORK, Dec. 04, 2024...
CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 NASHUA, N.H., Dec....
